In vivo, nucleophosmin-ALK expression during transgenic IL-9 expression led to the development of murine plasmacytoma, plasmoblastic/anaplastic lymphoma and precursor T-lymphoblastic lymphoma [27]. The gene discussed is IL9; the disease is T-lymphoblastic lymphoma.